These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3149342)

  • 41. The relationship between pharmacokinetic behaviour of glycyrrhizin and hepatic function in patients with acute hepatitis and liver cirrhosis.
    Yamamura Y; Tanaka N; Santa T; Kotaki H; Aikawa T; Uchino K; Osuga T; Sawada Y; Iga T
    Biopharm Drug Dispos; 1995 Jan; 16(1):13-21. PubMed ID: 7711280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Correlations between alpha fetoprotein levels and hepatic cytolysis in acute viral hepatitis].
    Corridori S; Pietrogrande M; Scevola D; Vender A; Cerrato P; Lago A
    Riv Emoter Immunoematol; 1980; 27(3-4):135-41. PubMed ID: 6176004
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chronic hepatitis of viral etiology].
    Loginov AS; Blok IuE
    Ter Arkh; 1988; 60(2):3-7. PubMed ID: 3130674
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of chronic non-A non-B hepatitis with human interferon beta: a preliminary study.
    Kiyosawa K; Sodeyama T; Nakano Y; Yoda H; Tanaka E; Hayata T; Tsuchiya K; Yousuf M; Furuta S
    Antiviral Res; 1989 Oct; 12(3):151-61. PubMed ID: 2516430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin.
    Nagao Y; Sata M; Tanikawa K; Kameyama T
    Kansenshogaku Zasshi; 1995 Aug; 69(8):940-4. PubMed ID: 7594790
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cyclosporin A in chronic active hepatitis. Results of a pilot study of 20 patients].
    Friedrich K; Henning H
    Z Gastroenterol; 1988 May; 26(5):265-70. PubMed ID: 3136600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment and prevention of chronic viral hepatitis].
    Lumio J; Vuoristo M
    Duodecim; 1994; 110(20):1883-92. PubMed ID: 7555802
    [No Abstract]   [Full Text] [Related]  

  • 48. Interferon for hepatitis C.
    Puoti C; Magrini A; Stati T; Rossi P; Montagnese F; Resta S
    Lancet; 1997 Feb; 349(9049):398-9. PubMed ID: 9033470
    [No Abstract]   [Full Text] [Related]  

  • 49. Glycyrrhizin as a vehicle for the application of triamcynolone in the treatment of recurrent aphthous stomatitis.
    Pisanty S; Azaz E; Segal R
    Pharm Acta Helv; 1984; 59(12):341-4. PubMed ID: 6522412
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 51. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
    Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surrogate endpoints and non-inferiority trials in chronic viral hepatitis.
    Gentile I; Borgia G
    J Hepatol; 2010 May; 52(5):778. PubMed ID: 20347500
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of chronic non-A, non-B hepatitis with a combination therapy of interferon and an immunopotentiator].
    Ooka T
    Nihon Rinsho; 1988 Dec; 46(12):2703-14. PubMed ID: 3149344
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.
    Takahara T; Watanabe A; Shiraki K
    J Hepatol; 1994 Oct; 21(4):601-9. PubMed ID: 7814808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The suppressive effect of glycyrrhizin on TSH secretion (author's transl)].
    Matsui J; Ariga Y; Nakajima K; Kudo S; Mizuno K
    Horumon To Rinsho; 1980 Jan; 28(1):57-61. PubMed ID: 7371207
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
    Numazaki K; Umetsu M; Chiba S
    Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The therapeutic effect of biphenyl-dimethyl-dicarboxylate (DDB) on certain abnormal laboratory parameters in chronic hepatitis.
    Zhang YX; Yu HQ; Shi JZ; Qi HB; Dong ZH; Xu HY
    J Tradit Chin Med; 1987 Jun; 7(2):137-8. PubMed ID: 3448395
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapeutic basis of glycyrrhizin on chronic hepatitis B.
    Sato H; Goto W; Yamamura J; Kurokawa M; Kageyama S; Takahara T; Watanabe A; Shiraki K
    Antiviral Res; 1996 May; 30(2-3):171-7. PubMed ID: 8783808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A double-blind study of strong neominophagen-C in treating chronic hepatitis].
    Wang JT
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):14-8, 62. PubMed ID: 6396046
    [No Abstract]   [Full Text] [Related]  

  • 60. [A case of pseudoaldosteronism induced by glycyrrhizin and study of all cases in Japan (author's transl)].
    Shio H
    Horumon To Rinsho; 1982 Jan; 30(1):57-62. PubMed ID: 7075016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.